Explore Hub
Comprehensive coverage and timeline for Record Highs. Aggregated from 30 sources with 46 articles.
46 articles · 30 sources · Coverage since 3/14/2026
How Record Highs coverage has developed over time.
Topics frequently covered alongside Record Highs.
Image: Briefs Finance• Singapore's electronics exports reached record highs recently as demand surged for AI-related servers, chips, and disk drives. • Export volumes for electronics grew by 132%, leading to an increase in overall economic growth forecasts. • Higher computing complexity and stricter cybersecurity requirements for AI deployment are expected to sustain long-term demand for the local chip complex.
briefs.co
Image: ProPublica• Measles cases are reaching record highs as immunization rates drop across various parts of the United States. • Health officials warn that measles is one of the most contagious diseases in history and is typically the first to resurface when vaccine coverage declines. • In response to the threat, some U.S. schools have established vaccination clinics to boost student immunity and prevent outbreaks.
propublica.org• European stocks retreated from record highs on Wednesday as investors balanced corporate earnings reports against escalating geopolitical risks in the Middle East. • Market sentiment was partially supported by a benign U.S. inflation reading, which reduced immediate fears that the Federal Reserve would implement an interest-rate hike next month. • The pullback reflects a cautious approach from traders who are weighing positive economic indicators against the volatility of regional conflicts and company performance.
tradingview.com• The pan-European Stoxx 600 index closed 0.16% lower at 659.48 points, retreating slightly from recent record highs. • Investors are currently balancing corporate earnings reports against escalating geopolitical risks in the Middle East. • This market movement reflects a cautious sentiment among traders as they weigh economic growth indicators against regional instability.
businesstimes.com.sg
Image: Emirates 24|7• European stocks remained near record highs on Wednesday as investors balanced corporate earnings reports with geopolitical instability. • Defence and energy shares saw specific gains driven by escalating global tensions, providing a boost to overall market indices. • Market participants are closely awaiting the release of US Consumer Price Index (CPI) inflation data to gauge the Federal Reserve's next move on interest rates.
emirates247.com
Image: The Globe and Mail• The TSX and S&P 500 both closed at record highs, with the Canadian benchmark achieving its largest weekly gain in four months. • Market optimism is driven by strong corporate performance, as 85.1% of the 436 S&P 500 companies reporting results so far have exceeded analyst expectations, surpassing the historical average of 68%. • This rally persists despite contradictory economic signals, including weak job numbers and higher inflation, which typically suggest a need for rate hikes rather than cuts.
theglobeandmail.com• European stock markets are currently maintaining positions near record highs despite conflicting market pressures. • Positive corporate earnings reports are providing upward support, but this growth is being offset by downward pressure within the technology sector. • The situation highlights a tug-of-war between strong fundamental company performance and volatility in high-growth tech valuations.
investing.com
Image: Euronews• The STOXX Europe 600 index has reached record highs, driven by a combination of strong corporate earnings and positive macroeconomic data. • Eurozone GDP growth for Q2 2026 hit 0.4% quarter-to-quarter, exceeding consensus expectations by 0.2 percentage points. • According to Pantheon Macroeconomics' chief economist Claus Vistesen, this growth follows an upward revision to zero growth in Q1, signaling a recovery in the region.
euronews.com
Image: BigGo Finance• The STOXX Europe 600 Index reached a record closing high for the second consecutive day on May 5, though overall gains were tempered by shifting Middle East peace hopes. • Novo Nordisk shares plummeted 4.3% after sales of the oral version of its obesity drug, Wegovy, failed to meet market expectations despite an increase in 2026 full-year guidance. • In the pharmaceutical sector, reports from Reuters indicated that AstraZeneca is not currently engaged in concrete merger talks with any U.S. companies.
finance.biggo.com• The Dow and S&P 500 reached new record highs, while the Nasdaq rose 2.59%, driven by a rebound in global risk appetite and AI-driven optimism. • Tech stocks led the rally, highlighted by massive gains for Palantir (29%) and ARM (over 17%), though SpaceX and AMD saw post-market sell-offs. • The surge was triggered by cooling inflation expectations, declining Treasury yields, and a reduction in risk premiums as U.S.-Iran geopolitical tensions eased.
tradingkey.com